Tango Therapeutics Inc is a biotechnology company. It is dedicated towards discovering novel drug targets and delivering the next generation of precision medicine for the treatment of cancer. Tango Therapeutics Inc is a biotechnology company. It is dedicated towards discovering novel drug targets and delivering the next generation of precision medicine for the treatment of cancer.
Tango Therapeutics, Inc. (NASDAQ: TNGX), a clinical-stage biotechnology company committed to discovering and delivering the next generation of precision cancer medicines, today announced that...
Tango Therapeutics, Inc. (NASDAQ: TNGX), a clinical-stage biotechnology company committed to discovering and delivering the next generation of precision cancer medicines, today announced that...
– Positive TNG462 clinical activity across multiple tumor types in the phase 1/2 clinical trial, program moving into full development with multiple combination studies – – Clinical collaboration...
– TNG462 demonstrated durable clinical activity across multiple tumor types, including non-small cell lung cancer (NSCLC) and pancreatic cancer, in ongoing phase 1/2 clinical trial, moving into...
Période | Variation | Variation % | Ouver. | Haut | Bas | Moyenne Vol. Quot. | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -0.67 | -17.2680412371 | 3.88 | 3.98 | 3.21 | 1082339 | 3.45584737 | CS |
4 | -0.27 | -7.75862068966 | 3.48 | 4.22 | 3.21 | 1894285 | 3.72944874 | CS |
12 | -6.49 | -66.9072164948 | 9.7 | 9.84 | 2.7 | 1862930 | 4.69587163 | CS |
26 | -3.55 | -52.5147928994 | 6.76 | 12.015 | 2.7 | 1332297 | 6.37466193 | CS |
52 | -6.03 | -65.2597402597 | 9.24 | 13.005 | 2.7 | 982516 | 7.32488532 | CS |
156 | -8.07 | -71.5425531915 | 11.28 | 13.03 | 2.47 | 692101 | 7.28011242 | CS |
260 | -6.4 | -66.5972944849 | 9.61 | 18.84 | 2.47 | 643431 | 7.4966959 | CS |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales